ADENOVIRUS-MEDIATED p53 GENE TRANSFER TO RAT TESTIS IMPAIRS SPERMATOGENESIS

REFERENCES

• Alc ivar AA, Hake LE, Hecht NB (1992): DNA polymerasep and poly (ADP) ribose polymerase mRNA are differentially expressed during the development of male germinal cells. Biol Reptiles 46:201–297.
   Google Scholar
• Almon E, Goldfinger N, Kapon A, Schwartz D, Levine AJ, Rotter V (1993): Testicular tissue-specific expression of the p53 suppressor gene. Dev Biol 156:107–116.
   Google Scholar
• Blagosklonny M, El-Deiry W (1996): ln vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug. Int J Cancer 67:386–392.
   PubMed Web of Science ®Google Scholar
• Blanchard KT, Boekelheide K (1997): Adenovirus-mediated gene transfer to rat testis in vivo. Biol Reprod 56:495–500.
   PubMed Web of Science ®Google Scholar
• Brody S, Crystal R (1994): Adenovirus-mediated in vivo gene transfer. Ann NY Acad Sci USA 716:90–103.
   PubMed Web of Science ®Google Scholar
• Chang E, Jang Y, Hao Z, Murphy G, Rait A, Fee W, Sussman H, Ryan P, Chiang Y, Pirollo K (1997): Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Arch Otolaryngol Head Neck Surg 123:507–512.
   Google Scholar
• Clayman G, El-Naggar A, Roth J, Zhang W, Goepfert H, Taylor D, Liu T (1995): In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55:1–6.
   PubMed Web of Science ®Google Scholar
• Diller L, Kassel J, Camille EN, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH (1990): p53 function as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10:5772–5781.
   PubMed Web of Science ®Google Scholar
• Eck S, Wilson J (1996): Gene-based therapy. In: The Pharmacological Basis of Therapeutics, 9th ed. Goodman and Gilman (Eds). New York: Mc-Graw-Hill, pp 77–101.
   Google Scholar
• Eliyhu D, Michalovitz D, Eliyahu D, Pinhasi-Kimhi O, Oren M (1989): Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci USA 86:8763–8767.
   Google Scholar
• Finlay CA, Hinds PW, Levine AJ (1989): The p53 proto-oncogene can act as a suppressor of trans-formalion. Cell 57:1083–1093.
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Grimm E, Mukhopadhyay T, Zhang W, Owen-Shaub L, Roth J (1994): Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediatedtransfer of the wild-type p53 gene. Cancer Res 54:2287–2291.
   PubMed Web of Science ®Google Scholar
• Graham FL, Prevec L (1995): Methods for construction of adenovirus vectors. Mol Biotech 3:207–212.
   PubMed Web of Science ®Google Scholar
• Hitt M, Belt A, Addison C, Prevec L, Graham F (1995): Technique for human adenovirus vector construction and characterization. Methods Mol Genet 7:13–30.
   Google Scholar
• Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkel BS, Vogelstein B, Fornace AJ (1992): A mammlian cell cycle checkpoint pathway utilizing p53 and GADD45 id defective in Ataxia-Telangiectasia. Cell 71:587–597.
   PubMed Web of Science ®Google Scholar
• Katayose D, Wersto R, Cowan K, Seth P (1995): Effects of a recombinant adenovirus expressing WAF1/CIP1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ 6:1207–1212.
   PubMedGoogle Scholar
• Ko S, Gotoh A, Thalmann G, Zhau H, Johnston D, Zhang W, Kao C, Chung L (1996): Molecular therapy with recombinant p53 adenovirus in an androgen-indeperrlent, metastatic human prostate cancer model. Hum Gene Therapy 7:1683–1691.
   Google Scholar
• Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tisty TD (1992): Altered cell cycle arrest and gene amplification potential accompany loss of wild type p53. Cell 70:923–935.
   PubMed Web of Science ®Google Scholar
• Meng R, Shih H, Prabhu N, Georg D, El-Deiry W (1998): Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression. Clin Cancer Res 4:251–259.
   PubMedGoogle Scholar
• Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich A (1990): Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170.
   PubMed Web of Science ®Google Scholar
• Michalovitz D, Halevy O, Oren M (1990): Conditional inhibition of transformation and of cell prolif-eration by a temperature-sensitive mutant p53. Cell 62:671–680.
   Google Scholar
• Muramatsu T, Shibata O, Ryoki S, Ohmori Y, Okumura J (1997): Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem Biophys Res Commun 233:45–49.
   PubMed Web of Science ®Google Scholar
• Rotter V, Schwartz D, Almon E, Goldfinger N, Kapon A, Meshorer A, Donehower LA, Levine AJ (1993): Proc Natl Acad Sci USA 90:9075–9079.
   Google Scholar
• Schwatz D, Goldfinger N, Rotter V (1993): Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 8:1487–1494.
   Google Scholar
• Seth P, FitzGerald D, Ginsberg H, Willingham M, Pastan 1(1984): Evidence that the protein base of adenovirus is involved in potentiation of toxicity pseudomonas exotoxin conjugated to epidermal growth factor. Mol Cell Biol 4:1528–1533.
   Google Scholar
• Shaulsky G, Ben Ze'ev A, Rotter V (1990): Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1707–1711.
   Google Scholar
• Shaulsky S, Goldfinger N, Peled A, Rotter V (1991): Involvement of wild type p53 protein in the cell cycle requires nuclear localization. Cell Growth Diff 2:661–667.
   Google Scholar
• Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J (1992): Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495–4499.
   PubMed Web of Science ®Google Scholar
• Shirakawa T, Gotoh A, Gardner TA, Kao C, Zhang ZI, Matsubara S, Wada Y, Hinata N, Fujisawa M, Hanioka K, Matsuo M, Kamidono S (2000): P53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibilion of primary cultures of human and an experimental rat model. J Gene Med 2:426–432.
   PubMed Web of Science ®Google Scholar
• Taneja S, Pang S, Cohan P, Belldegrun A (1995): Gene therapy: principles and potential. Cancer Surv 23:247–266.
   Google Scholar
• Tsukuda T, Tomooka Y, Takai S (1993): Enhanced proliferative potential in culture cells from p53 deficient mice. Oncogene 8:3313.
   Google Scholar
• Yin Y, Dewolf WC, Morgentaler A (1998): Experimental cryptorchidism induces testicular germ cell apoptosis by p53-dependent and -independent pathways in mice. Biol Reprod 58:492–496.
   PubMed Web of Science ®Google Scholar
• Yin Y, Stahl BC, DeWolf WC, Morgentaler A (1998): p53-mediated germ cell quality control in spermatogenesis. Dev Biol 204:165–171.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991): Wild-type p53 induces apoptosis myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345–347.
   PubMed Web of Science ®Google Scholar
• Zhang W, Fang X, Mazur W, French B, Roth J (1993): Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 15:868–872.
   PubMed Web of Science ®Google Scholar